Literature DB >> 16339160

Role of HCV coinfection towards disease progression and survival in HIV-1 infected children: a follow-up study of 10 years.

Swami Onkar Shivraj1, Debasish Chattopadhya, Gurprit Grover, Ashok Kumar, Usha K Baveja.   

Abstract

The present study was taken up to evaluate the pattern of disease progression and survival in a group of HIV-1 positive children, coinfected with HCV infection (n=25) in comparison to those without such coinfection (n=23). There was a significant negative correlation between the rate of decline of the CD4 + T cell percentage and the duration of the AIDS-free interval in most (80.0 per cent) of the HCV seropositive children showing such decline (r=-0.588; p=0.005). The HCV seropositive children had twofold higher risk of progression to development of AIDS than HCV seronegatives (RR=2.51; 95 per cent CI:1.34-4.69; p=0.004). There was a significant negative correlation between the rate of decline of CD4 + T cell percentage and overall survival duration for HCV seropositive group (r=-0.609; p=0.003). Moreover, children coinfected with HCV had more than twofold higher risks of death than those without HCV (RR=2.39; 95 per cent CI:1.17-4.89; p<0.01). It appears that HCV infection may be an important contributor to the rapid disease progression and increase in mortality in HCV-HIV-1 coinfected children of thalassemia major.

Entities:  

Mesh:

Year:  2005        PMID: 16339160     DOI: 10.1093/tropej/fmi103

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  7 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection.

Authors:  Jinjin Zhang; Andrea Mulvenon; Edward Makarov; Jill Wagoner; Jaclyn Knibbe; Jong Oh Kim; Natalia Osna; Tatiana K Bronich; Larisa Y Poluektova
Journal:  Biomaterials       Date:  2013-02-10       Impact factor: 12.479

3.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

4.  Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009.

Authors:  Shuntai Zhou; Yan Zhao; Yun He; Huiqin Li; Marc Bulterys; Xin Sun; Zhihui Dou; Matthew Robinson; Fujie Zhang
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

5.  HCV coinfection associated with slower disease progression in HIV-infected former plasma donors naïve to ART.

Authors:  Xiaoyan Zhang; Jianqing Xu; Hong Peng; Yan Ma; Lifeng Han; Yuhua Ruan; Bing Su; Ning Wang; Yiming Shao
Journal:  PLoS One       Date:  2008-12-22       Impact factor: 3.240

6.  Effects of HCV on basal and tat-induced HIV LTR activation.

Authors:  Satarupa Sengupta; Eleanor Powell; Ling Kong; Jason T Blackard
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

7.  Variation in host susceptibility and infectiousness generated by co-infection: the myxoma-Trichostrongylus retortaeformis case in wild rabbits.

Authors:  Isabella M Cattadori; Réka Albert; Brian Boag
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.